...
首页> 外文期刊>Hepatitis Monthly >DIFFERENTIAL EXPRESSION OF WNT PATHWAY GENES IN SPORADIC HEPATOCELLULAR CARCINOMAS INFECTED WITH HEPATITIS B VIRUS IDENTIFIED WITH OLIGOGE ARRAYS
【24h】

DIFFERENTIAL EXPRESSION OF WNT PATHWAY GENES IN SPORADIC HEPATOCELLULAR CARCINOMAS INFECTED WITH HEPATITIS B VIRUS IDENTIFIED WITH OLIGOGE ARRAYS

机译:WNT通路基因在肝癌B型肝炎病毒感染的少发性肝细胞癌中的WNT通路基因差异表达

获取原文
           

摘要

Background: Epidemiological evidence has clearly indicated that chronic infection with the hepatitis B virus (HBV) is the major risk factor for developing hepatocellular carcinoma (HCC). Nonetheless, the mechanisms by which HBV contributes to the pathogenesis of HCC have not been fully elucidated. Objectives: Our aim was to characterize differential gene expression profiles related to the Wnt signaling pathway between primary tumor and adjacent normal tissues in HCC patients with concomitant HBVinfection. Materials and Methods: An oligoGEArray ? (an oligonucleotide-based gene expression array platform) containing 126 Wnt signaling pathway-related genes was used to compare gene expressions between primary HCC and adjacent non-tumorous liver tissues from 10 patients with HCC. Selected differential genes were identified with real-time RT-PCR and immunohistochemistry (IHC). In particular, the protein of the differential gene DVL3 (disheveled, dsh homolog 3 [Drosophila]) was chosen to investigate whether it is up regulated in primary tumor correlated with the clinic pathological characteristics of HCC patients. For this purpose we examined 56 HCC tissue samples via IHC for the presence of DVL3 protein.Results: Sixteen genes were identified with significant differential expression between HCC and adjacent non-tumorous liver tissue. These genes have been previously associated with the Frizzled signaling pathway, cell cycle, transcription, or protein degradation. All (100%) of the tumor samples results from 56 HCC patients tested were positive for DVL3 via IHC. Based on the intensity of DVL3 immunoreactivity, 25 (44.6%) and 31 (55.4%) of the patients were classified aslow and high-DVL3, respectively, which correlated with tumor stage (P=0.029). Conclusions: This study clarified a number of Wnt pathway-related genes which are dysregulated in HBV-associated HCC. These genes may be contributedto the frequent activation of the Wnt signaling pathway. Our results promote the role of the Wnt signaling pathway in HBV- associated HCC.
机译:背景:流行病学证据已明确表明,慢性乙型肝炎病毒(HBV)感染是发展为肝细胞癌(HCC)的主要危险因素。然而,尚未完全阐明HBV促成HCC发病机理的机制。目的:我们的目的是鉴定与伴发HBV感染的HCC患者原发肿瘤和邻近正常组织之间的Wnt信号通路相关的差异基因表达谱。材料和方法:oligoGEArray? (基于寡核苷酸的基因表达阵列平台)包含126个Wnt信号通路相关基因,用于比较10例HCC患者原发性HCC与相邻非肿瘤肝组织之间的基因表达。通过实时RT-PCR和免疫组化(IHC)鉴定选定的差异基因。特别是,选择了差异基因DVL3的蛋白质(去杂化的dsh同源物3 [Drosophila])来研究其在原发肿瘤中是否与HCC患者的临床病理特征有关而被上调。为此,我们通过IHC检查了56例HCC组织样本中是否存在DVL3蛋白。结果:鉴定出16个基因,在HCC与邻近的非肿瘤肝组织之间存在显着差异表达。这些基因先前已与卷曲信号通路,细胞周期,转录或蛋白质降解相关。测试的56例HCC患者的所有肿瘤样品结果(100%)通过IHC对DVL3呈阳性。根据DVL3免疫反应的强度,分别将25(44.6%)和31(55.4%)位患者分类为低DVL3和高DVL3,这与肿瘤分期相关(P = 0.029)。结论:这项研究阐明了在与HBV相关的HCC中失调的许多Wnt通路相关基因。这些基因可能有助于Wnt信号通路的频繁激活。我们的结果促进了Wnt信号通路在HBV相关HCC中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号